🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Followers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Sellers market the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering products of unknown origin.

Several professionals said the demand for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Reaction and Material Removal

Based on the social media company, the service has removed problematic content and banned related hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Research also discovered communities with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays channels with numerous of members, populated with images of slimming results, glowing testimonials and step-by-step instructions for preparing or injecting at home.

After minutes of joining one group, a seller posted WhatsApp details, where the majority of purchases occur. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, posts show black plastic parcels with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how long a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Although the research behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already encountered patients injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to potentially serious medical dangers”.